Intrinsic Value

The intrinsic value of Health Catalyst Inc (2YP) under the Base Case is 1.72 EUR per share. Compared with the current market price of 1.35 EUR, the stock appears Undervalued by 21% .

The intrinsic value is calculated using the DCF method.

Do our valuations actually work? See backtest results .

2YP Intrinsic Value
€1.72
Undervaluation 21%
Intrinsic Value
Price €1.35
Alert me when 2YP is below its intrinsic value
Today €1.20 · 11.0% below the current price

2YP is cheaper than usual. It was this cheap or cheaper on just 6% of days in the past 5 years.

Alternatives to 2YP

Fundamental Analysis

What Health Catalyst Does

Health Care

Health Catalyst makes software and services that help hospitals and health systems organize clinical and financial data, analyze performance, and improve care delivery. Its products pull data from many hospital systems into one place, then turn it into dashboards, reports, and decision support tools that managers and clinicians use to spot inefficiencies, track outcomes, and manage costs.

Headquarters
United States of America US
Employees
1 200
IPO date
Jul 25, 2019
Read the full company overview
View Company Overview
Financials
Efficiency

Earnings Waterfall
Health Catalyst Inc

Wall St Price Targets

Capital Returns

Competitive Landscape

Ownership

HCAT Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one 2YP stock?

The intrinsic value for Health Catalyst Inc (2YP) under the Base Case is 1.72 EUR.

Is 2YP stock undervalued or overvalued?

Compared with the current market price of 1.35 EUR, the stock appears Undervalued by 21% .

Back to Top